Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Nov;74(9):1329–1330. doi: 10.1038/bjc.1996.544

How best to express oestrogen receptor activity.

R A Hawkins
PMCID: PMC2074796  PMID: 8912524

Full text

PDF
1329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman D. G. Categorising continuous variables. Br J Cancer. 1991 Nov;64(5):975–975. doi: 10.1038/bjc.1991.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell F. C., Blamey R. W., Elston C. W., Morris A. H., Nicholson R. I., Griffiths K., Haybittle J. L. Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy. Lancet. 1981 Dec 12;2(8259):1317–1319. doi: 10.1016/s0140-6736(81)91341-6. [DOI] [PubMed] [Google Scholar]
  3. De Placido S., Gallo C., Marinelli A., Perrone F., Pagliarulo C., Petrella G., Delrio G., D'Istria M., Del Mastro L., Bianco A. R. Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study. Breast Cancer Res Treat. 1990 Sep;16(2):111–117. doi: 10.1007/BF01809295. [DOI] [PubMed] [Google Scholar]
  4. GLASCOCK R. F., HOEKSTRA W. G. Selective accumulation of tritium-labelled hexoestrol by the reproductive organs of immature female goats and sheep. Biochem J. 1959 Aug;72:673–682. doi: 10.1042/bj0720673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. King W. J., DeSombre E. R., Jensen E. V., Greene G. L. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res. 1985 Jan;45(1):293–304. [PubMed] [Google Scholar]
  6. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  7. Leclercq G., Heuson J. C. Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer. Eur J Cancer. 1977 Nov;13(11):1205–1215. doi: 10.1016/0014-2964(77)90026-3. [DOI] [PubMed] [Google Scholar]
  8. McGuire W. L., Horwitz K. B., Zava D. T., Garola R. E., Chamness G. C. Hormones in breast cancer: update 1978. Metabolism. 1978 Apr;27(4):487–501. doi: 10.1016/0026-0495(78)90103-8. [DOI] [PubMed] [Google Scholar]
  9. Robertson J. F. Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer. 1996 Jan;73(1):5–12. doi: 10.1038/bjc.1996.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Shek L. L., Godolphin W. Survival with breast cancer: the importance of estrogen receptor quantity. Eur J Cancer Clin Oncol. 1989 Feb;25(2):243–250. doi: 10.1016/0277-5379(89)90015-1. [DOI] [PubMed] [Google Scholar]
  11. Simon R., Altman D. G. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994 Jun;69(6):979–985. doi: 10.1038/bjc.1994.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Walt A. J., Singhakowinta A., Brooks S. C., Cortez A. The surgical implications of estrophile protein estimations in carcinoma of the breast. Surgery. 1976 Oct;80(4):506–512. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES